[Case Study] Shogo Otake and Masashi Kasai “AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria” (AMR Alliance Japan, October 12, 2021)
date : 10/12/2021
Tags: AMR
![[Case Study] Shogo Otake and Masashi Kasai “AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria” (AMR Alliance Japan, October 12, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-case02-top_ENG.jpg)
As part of the Alliance’s project to promote antimicrobial stewardship, AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun publishing case studies from various experts related to antimicrobial resistance.
Dr. Shogo Otake and Dr. Masashi Kasai (Department of Infectious Diseases, Hyogo Prefectural Kobe Children’s Hospital) reports a case titled “AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria.”
Case study 02
Dr. Shogo Otake and Dr. Masashi Kasai (Department of Infectious Diseases, Hyogo Prefectural Kobe Children’s Hospital)
“AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria”
For further information, please see the case study below.
Case study 01
Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)
“A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment”
![[AMR Case Study 02] AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria](/assets/img/katsudo/icon_pdf_l.png){kind=icon}
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
![[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_3rd_nominations_eyecatch_caseB_ENG_web_20260929_v0.5.jpg)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
![[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261001_Eyecatch_HGPIseminer-146th-1.png)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
![[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20261016_Policy-Column-2-Blood-Disorders.png)
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)
![[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/PolicyRecommendations_IntractableAndRareDiseas.jpg)
